Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Genmab A/S    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about GENMAB A/S
12/03GENMAB A/S : Announces that Janssen has Submitted a Biologics License Applicatio..
AQ
12/01GENMAB A/S : Investor Presentation - December 2020
PU
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24Genmab Announces Enapotamab Vedotin Update
GL
11/24GENMAB A/S : Mereo BioPharma Group plc - Mereo BioPharma Appoints Suba Krishnan,..
AQ
11/13GENMAB A/S : 2020 Virtual Capital Markets Day – November 13, 2020
PU
11/11GENMAB A/S : Articles of association dated November 10, 2020 – English
PU
11/11GENMAB A/S : BioNTech Announces Third Quarter 2020 Financial Results and Corpora..
AQ
11/10GENMAB A/S : Capital Increase in Genmab as a Result of Employee Warrant Exercise
AQ
11/10GENMAB A/S : to Present at Jefferies Virtual London Healthcare Conference
AQ
11/06GENMAB A/S : Announces Phase 3 Study Evaluating Epcoritamab in Patients with Rel..
AQ
11/06GENMAB A/S : Announces that Janssen has submitted a Type II Variation Applicatio..
AQ
11/05GENMAB A/S : Announces Phase 3 Study Evaluating Epcoritamab in Patients with Rel..
AQ
11/05GENMAB A/S : Announces Phase 3 Study Evaluating Epcoritamab in Patients with Rel..
AQ
More most relevant news
All news about GENMAB A/S
12/03GENMAB A/S : Announces that Janssen has Submitted a Biologics License Applicatio..
AQ
12/01GENMAB A/S : Investor Presentation - December 2020
PU
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24Genmab Announces Enapotamab Vedotin Update
GL
11/24GENMAB A/S : Mereo BioPharma Group plc - Mereo BioPharma Appoints Suba Krishnan,..
AQ
11/20IMMUNOPRECISE ANTIBODIES : and Genmab Enter into a Technology Partnership Target..
AQ
11/13GENMAB A/S : 2020 Virtual Capital Markets Day – November 13, 2020
PU
11/11GENMAB A/S : Articles of association dated November 10, 2020 – English
PU
More news
News in other languages on GENMAB A/S
11/23Thanksgiving et Covid ne font pas bon ménage
11/23AVIS D'ANALYSTES DU JOUR : ASML, BMW, Crédit Suisse, Genmab, HelloFresh, Orsted,..
11/16Des idées d'ETF pour miser sur le retour en grâce des valeurs moyennes
11/16AVIS D'ANALYSTES DU JOUR : Adidas, Alcon, Continental, Engie, Neste, Scout24, St..
10/30GENMAB A/S : Veröffentlichung des Quartalsergebnisses
10/30GENMAB A/S : publication des résultats trimestriels
10/2320 valeurs de croissance cotées en Europe
10/22GENMAB : résultats d'un médicament contre le cancer
09/25TOUR DU MONDE DES INDICES :  Tesla-dépendance et irréductibles danois
09/23GENMAB : procédure d'arbitrage à l'encontre de Janssen
Analyst Recommendations on GENMAB A/S
07/24GLAXOSMITHKLINE : GSK's blood cancer drug wins European panel thumbs-up
RE
07/24GENMAB A/S : GSK's blood cancer drug wins European panel thumbs-up
RE
07/14GLAXOSMITHKLINE : FDA panel votes in favor of approving GSK's multiple myeloma d..
RE
05/28GENMAB : Darzalex Meets Main Endpoint in Light-Chain Amyloidosis Study
DJ
More recommendations
Press releases
12/03GENMAB A/S : Announces that Janssen has Submitted a Biologics License Applicatio..
AQ
12/01GENMAB A/S : Investor Presentation - December 2020
PU
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
More press releases